Rohan Samson is a Cardiology physician affiliated with UofL Health. OpenAlex indexes 76 publications with 829 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck & Co.Program year20251 paymentResearch$180,119
- E.R. Squibb & Sons, L.L.C.Program year202553 payments$77,845
- Boston Scientific CorporationProgram year202513 payments$481
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.1%Beta blocker18.7%Metoprolol Succinate72%Carvedilol28%Part D≥55 patientsLoop diuretic14%Bumetanide55%Furosemide33%Torsemide12%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
17%Potassium supplement8%Potassium Chloride81%Klor-Con M2019%Part D<11 patientsSGLT2 inhibitor4.5%Jardiance58%Farxiga42%Part D<11 patients+ 3 more classes in this area
Blood & clotting
6.3%Factor Xa inhibitor3.5%Eliquis100%Part D≥15 patientsP2Y12 inhibitor2.8%Clopidogrel100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Isaac Abecassis, MD
UofL Health
Redi Rahmani, MD
UofL Health
Mohamed Hegazi, MD
UofL Health
Rohit Kumar, MD
UofL Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”